OTHER INFORMATION
−Removed: During the quarter
−Removed: ended September 30, 2024, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule
−Removed: 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
+Added: During the quarter ended March 31,
+Added: 2025, no Director or Officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1
+Added: trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 *
1 unchanged sentence
Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 **
−Removed: Inline XBRL Document Set
−Removed: for the financial statements and accompanying notes in Part I, Item 1, of this Quarterly Report on Form 10-Q.*
−Removed: Inline XBRL for the cover
−Removed: page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document Set.*
−Removed: __________________
+Added: Inline XBRL Document Set for the financial statements and accompanying notes in Part I, Item 1, of this Quarterly Report on Form 10-Q.*
+Added: Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document Set.*
Filed herewith.
−Removed: Pursuant to the
−Removed: requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
−Removed: thereunto duly authorized, on November 5, 2024.
+Added: Furnished herewith.
+Added: Pursuant to the requirements of the Securities Exchange
+Added: Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized, on May
SUNSHINE BIOPHARMA INC.
2 unchanged sentences
Camille Sebaaly
−Removed: Chief Financial Officer (principal financial and accounting
+Added: Chief Financial Officer (principal financial and accounting officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.